Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

FUL

H.B. Fuller Q3 2026 Revenue Up 5.2% to $938M

H.B. Fuller reported third-quarter 2026 net revenue of $938 million, up 5.2% from a year earlier, as pricing added 7.4 percentage points and more than offset lower volume. Organic revenue rose 4.4%, with foreign currency translation contributing 0.7% and acquisitions 0.1%.

Adjusted EBITDA increased 9% year over year to $187 million, lifting adjusted EBITDA margin to 19.9% from 19.1% a year ago, an 80-basis-point improvement. Gross margin was 33.2%, while adjusted gross margin reached 33.5%, up 120 basis points from last year.

Net income was $79 million. Adjusted net income was $83 million. Reported diluted earnings per share were $1.44, while adjusted diluted EPS rose 21% to $1.52 from the prior-year period.

Selling, general and administrative expense totaled $198 million, while adjusted SG&A was $183 million, up 8% year over year but down 7% sequentially from the second quarter, reflecting the timing of certain expenses.

For the first nine months of fiscal 2026, cash flow from operations reached $183 million, up 17% from the same period last year. Net debt was $1.957 billion, roughly unchanged year over year, but net debt-to-adjusted EBITDA improved to 3.0x from 3.3x at the end of the third quarter of fiscal 2025.

Working capital increased to 18.5% of annualized net revenue, up 150 basis points year over year, driven mainly by inventory investments. As a result of these announcements, the company's shares have moved -1.68% on the market, and are now trading at a price of $50.21. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS